Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-527-6 | CAS number: 107-86-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian cell study: DNA damage and/or repair
- Remarks:
- Type of genotoxicity: DNA damage and/or repair
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP and guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 001
- Report date:
- 2001
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 486 (Unscheduled DNA Synthesis (UDS) Test with Mammalian Liver Cells in vivo)
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- testing lab.
- Type of assay:
- unscheduled DNA synthesis
Test material
- Reference substance name:
- 3-methyl-2-butenal
- EC Number:
- 203-527-6
- EC Name:
- 3-methyl-2-butenal
- Cas Number:
- 107-86-8
- Molecular formula:
- C5H8O
- IUPAC Name:
- 3-methyl-2-butenal
- Details on test material:
- - Name of test material (as cited in study report): 3-Methyl-2-butenal, CAS: 107-86-8; Substance-No. 00/0680-1
- Analytical purity: 97%
- Physical state: Colorless to yellowish liquid
- Lot/batch No.: B 3290 from 28.08.2000
- Storage condition of test material: Room temperature (N2 conditions)
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Deutschland GmbH
- Age at study initiation: 10 - 12 weeks
- Weight at study initiation: mean weight of about 254 g
- Assigned to test groups randomly: randomization plan prepared with an appropriate computer program
- Housing: individually in Makrolon cages, type III, for the duration of about one week (until treatment) in fully air-conditioned rooms
- Diet: Standardized pelleted feed (Kliba-Haltungsdiät/Provimi Kliba SA, Kaiseraugst, Switzerland) ad libitum
- Water: ad libitum
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 24°C
- Humidity (%): 30 - 70%
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: water
- Justification for choice of solvent/vehicle: In comparison to other commonly used vehicles (e .g. DMSO, corn oil etc.) water is the most suitable (formation of an emulsion). Therefore, water was selected as vehicle.
- Concentration of test material in vehicle: 3.5 g/100 ml - Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
All test substance formulations were prepared immediately before administration.
The UDS test measures DNA repair synthesis after excision and removal of a stretch of DNA containing the region of the damage induced. Repair is detected by the incorporation of tritrium-labeled thymidine (3H-thymidine) into the DNA that was not in the normal phase of the DNA synthesis (S-phase) and is determined by autoradiography. Cells undergoing repair are identified by an increase in the number of silver grains overlying the nuclei. - Duration of treatment / exposure:
- single dose
- Frequency of treatment:
- single application
- Post exposure period:
- none, animals were immediately killed after 3 and 14 hrs, respectively
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 350, 700 mg/kg bw
Basis:
nominal conc.
- No. of animals per sex per dose:
- 3 (males only)
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- - Positive control substances: 2-acetylaminofluorene
- Justification for choice of positive control(s): 2-AAF is a well-established UDS-inducing agent
- Route of administration: oral
- Doses / concentrations: 50 mg kg bw (10 ml/kg bw)
Examinations
- Tissues and cell types examined:
- rat hepatocytes
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION:
In a pretest for the determination of the acute oral toxicity, deaths were observed down to a dose of 800 mg/kg body weight. 700 mg/kg were survived by all animals, but led to strong clinical signs such as abdominal position, squatting posture, piloerection, tremor, salivation, gasping respiration, eye discharge and eyelid closure ; the general state of the animals was poor. Therefore, a dose of 700 mg/kg body weight was selected as the highest dose in the present study; 350 mg/kg body weight were administered as further doses.
DETAILS OF SLIDE PREPARATION:
The isolated hepatocytes were seeded on coverslips on 1 .9 cm2 well containing 2 ml of attachment medium (WMEC).
• about 400,000 viable cells were seeded per well.
• 6 wells per animal were used for the UDS assay.
After an attachment period of about 2 hours with 5% CO2 at 37°C and >= 90% humidity, the medium (WMEC) was replaced by fresh medium (WMEI) to remove non-adherent cells. - Evaluation criteria:
- The quantification of UDS was performed microscopically using 2 or 3 slides per test group. 25 - 50 cells in good morphological conditions were randomly selected per slide and examined to achieve a total number of 100 cells/animal.
A test substance is considered positive if a dose-related increase is demonstrated in both of the following :
• The mean number of NNG counts, which must exceed zero at one of the test points .
• The percentage of cells in repair (NNG >= 5) when >= 20 .
A dose-related increase in % cells in repair >= 5 outside the values of both the concurrent negative control and the historical control data base (>= 5 < 20) and a dose-related increase in the mean number of NNG counts near to but without exceeding zero is considered to be an indication for a marginal response which needs to be confirmed / clarified in a further experiment.
A test article producing both NNG counts and % cells in repair in the range of the negative control data is considered to be negative in the in vitro UDS assay. - Statistics:
- Due to clear negative findings, a statistical evaluation was not carried out.
Results and discussion
Test results
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
- Dose range: 0-800 mg/kg bw
- Clinical signs of toxicity in test animals: abdominal position, squatting posture, piloerection, tremor, salivation, gasping respiration, eye discharge, eyelid closure; the general state of the animals was poor
The single oral administration of the test substance in a dose of 700 mg/kg body weights led to evident signs of toxicity; 350 mg/kg body weight were tolerated without any signs is or symptoms.
Hepatocytes were harvested 3 and 14 hours after administration of the test substance.
As a negative control, male rats were administered merely the vehicle, purified water, by the same route, which gave frequencies of mean nuclear net grain counts within the historical control range.
The positive control chemical 2-acetylaminofluorene (2-AAF) administered once orally in a dose of 50 mg/kg body weight demonstrated the expected increase in unscheduled DNA synthesis.
On the basis of the results from the present study, the single oral treatment with the test substance did not lead to an increase in the mean number of net nuclear grain counts at any dose level or exposure time in rat hepatocytes.
Any other information on results incl. tables
Test groups |
Vehicle control |
350 mg/kg |
700 mg/kg |
positive control |
NG counts Mean ± SD** |
4.88 ± 1.33 |
5.04 ± 0.89 |
4.70 ± 0.1 5 |
15.89 ± 3.01 |
CG counts Mean ± SD** |
9.35 ± 1.69 |
9.17 ± 1.45 |
8.67 ± 0.93 |
10 .05 ± 1.96 |
NNG counts Mean ± SD** |
-4.48 ± 0.37 |
-4.13 ± 0.70 |
-3.97 ± 0.78 |
5.84 ± 1.1 5 |
% cells in repair NNG ≥ 0 Mean ± SD** |
9.67 ± 1.53 |
8.67 ± 4 .04 |
9.00 ± 3.6 1 |
86.67 ± 5.5 1 |
% cells in repair NNG ≥ 5 Mean ± SD** |
0.00 ± 0.00 |
0.00 ± 0.00 |
0.00 ± 0.00 |
51.33 ± 2.52 |
DNA repair activity - perfusion 3 hours after treatment |
Test groups |
Vehicle control |
350 mg/kg |
700 mg/kg |
positive control |
NG counts Mean ± SD** |
4.78 ± 0.74 |
4.33 ± 0.44 |
5.24 ± 0.32 |
16.63 ± 2.24 |
CG counts Mean ± SD** |
8.92 ± 0.54 |
8.20 ± 0.76 |
9.36 ± 0.97 |
9.58 ± 1.05 |
NNG counts Mean ± SD** |
-4.14 ± 0.24 |
-3.87 ± 0.68 |
-4.12 ± 0.70 |
7.05 ± 1.25 |
% cells in repair NNG ≥ 0 Mean ± SD** |
9.00 ± 3.61 |
8.33 ± 4.93 |
8.67 ± 0.58 |
88.00 ± 2.65 |
% cells in repair NNG ≥ 5 Mean ± SD** |
0.00 ± 0.00 |
0.00 ± 0.00 |
0.00 ± 0.00 |
57.67 ± 2.89 |
DNA repair activity - perfusion 14 hours after treatment |
NG: nuclear grains
CG: cytoplasmic grains
NNG: net nuclear grains
** = mean per group (mean of 3 animals )
SD = standard deviation
Clinical examination:
The single oral administration of the vehicle in a volume of 10 ml/kg body weight was tolerated by all animals without any signs or symptoms .
The oral administration of the test substance in a dose of 700 mg/kg led to strong clinical signs. 350 mg/kg were tolerated without any signs or symptoms.
The single administration of the positive control substance 2-AAF in a dose of 50 mg/kg body weight did not cause any evident signs of toxicity.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
Under the experimental conditions of this assay, the test article 3-Methyl-2-butenal is considered to be negative in the in vivo UDS assay using rat hepatocytes.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.